Characterization of miRNomes in Acute and Chronic Myeloid Leukemia Cell Lines

Genomics, Proteomics and Bioinformatics

Volumn 12, Issue 2, 2014, Pages 79-91

  Xiong, Qian ^a,b   Yang, Yadong ^a   Wang, Hai ^a   Li, Jie ^a,b   Wang, Shaobin ^a   Li, Yanming ^a,b   Yang, Yaran ^a   Cai, Kan ^a   Ruan, Xiuyan ^a   Yan, Jiangwei ^a   Hu, Songnian ^a   Fang, Xiangdong ^a  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Acute myeloid leukemia; Chronic myeloid leukemia; MiRNA profiling; Myeloid differentiation

Indexed keywords

CD135 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; MICRORNA; MICRORNA 107; MICRORNA 10A; MICRORNA 124; MICRORNA 125B; MICRORNA 126; MICRORNA 127; MICRORNA 128; MICRORNA 140; MICRORNA 144; MICRORNA 146B; MICRORNA 15A; MICRORNA 181A; MICRORNA 185; MICRORNA 191; MICRORNA 20A; MICRORNA 21; MICRORNA 22; MICRORNA 221; MICRORNA 25; MICRORNA 30E; MICRORNA 320A; MICRORNA 376A; MICRORNA 451; MICRORNA 486; RETINOIC ACID RECEPTOR ALPHA; TRANSFER RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMOGENESIS; PROTEIN EXPRESSION;

ACUTE MYELOID LEUKEMIA; CHRONIC MYELOID LEUKEMIA; MIRNA PROFILING; MYELOID DIFFERENTIATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MICRORNAS;

EID: 84900988556     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2014.02.001     Document Type: Article

References (91)

1. Bissels U., Bosio A., Wagner W. MicroRNAs are shaping the hematopoietic landscape. Haematologica 2012, 97:160-167.
2. Murati A., Brecqueville M., Devillier R., Mozziconacci M.J., Gelsi-Boyer V., Birnbaum D. Myeloid malignancies: mutations, models and management. BMC Cancer 2012, 12:304.
3. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975, 45:321-334.
4. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977, 270:347-349.
5. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
6. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
7. Kozomara A., Griffiths-Jones S. MiRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014, 42:D68-D73.
8. Garzon R., Volinia S., Liu C.G., Fernandez-Cymering C., Palumbo T., Pichiorri F., et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111:3183-3189.
9. Mi S., Lu J., Sun M., Li Z., Zhang H., Neilly M.B., et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A 2007, 104:19971-19976.
10. Zhi F., Cao X., Xie X., Wang B., Dong W., Gu W., et al. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One 2013, 8:e56718.
11. Fayyad-Kazan H., Bitar N., Najar M., Lewalle P., Fayyad-Kazan M., Badran R., et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med 2013, 11:31.
12. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012, 13:358-369.
13. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10:57-63.
14. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
15. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
16. Yuan J.Y., Wang F., Yu J., Yang G.H., Liu X.L., Zhang J.W. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009, 13:4551-4559.
17. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
18. Garzon R., Liu S., Fabbri M., Liu Z., Heaphy C.E., Callegari E., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418.
19. Flamant S., Ritchie W., Guilhot J., Holst J., Bonnet M.L., Chomel J.C., et al. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010, 95:1325-1333.
20. Starczynowski D.T., Morin R., McPherson A., Lam J., Chari R., Wegrzyn J., et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood 2011, 117:595-607.
21. Daschkey S., Rottgers S., Giri A., Bradtke J., Teigler-Schlegel A., Meister G., et al. MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One 2013, 8:e56334.
22. Wang H., Hu H., Zhang Q., Yang Y., Li Y., Hu Y., et al. Dynamic transcriptomes of human myeloid leukemia cells. Genomics 2013, 102:250-256.
23. Huang P.J., Liu Y.C., Lee C.C., Lin W.C., Gan R.R., Lyu P.C., et al. DSAP: deep-sequencing small RNA analysis pipeline. Nucleic Acids Res 2010, 38:W385-W391.
24. Vaz C., Ahmad H.M., Sharma P., Gupta R., Kumar L., Kulshreshtha R., et al. Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics 2010, 11:288.
25. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261.
26. Nagpal N., Ahmad H.M., Molparia B., Kulshreshtha R. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 2013, 34:1889-1899.
27. Kumar M., Lu Z., Takwi A.A., Chen W., Callander N.S., Ramos K.S., et al. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 2011, 30:843-853.
28. Volinia S., Galasso M., Costinean S., Tagliavini L., Gamberoni G., Drusco A., et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010, 20:589-599.
29. An J., Lai J., Lehman M.L., Nelson C.C. MiRDeep*: an integrated application tool for miRNA identification from RNA sequencing data. Nucleic Acids Res 2013, 41:727-737.
30. Dore L.C., Amigo J.D., Dos Santos C.O., Zhang Z., Gai X., Tobias J.W., et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci U S A 2008, 105:3333-3338.
31. Bruchova-Votavova H., Yoon D., Prchal J.T. MiR-451 enhances erythroid differentiation in K562 cells. Leuk Lymphoma 2010, 51:686-693.
32. Wang F., Yu J., Yang G.H., Wang X.S., Zhang J.W. Regulation of erythroid differentiation by miR-376a and its targets. Cell Res 2011, 21:1196-1209.
33. * inhibits erythropoiesis from human embryonic stem cells. Blood 2011, 117:2157-2165.
34. Xiao F., Zuo Z., Cai G., Kang S., Gao X., Li T. MiRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009, 37:D105-D110.
35. Dixon-McIver A., East P., Mein C.A., Cazier J.B., Molloy G., Chaplin T., et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008, 3:e2141.
36. Marcucci G., Radmacher M.D., Maharry K., Mrózek K., Ruppert A.S., Paschka P., et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1919-1928.
37. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979, 54:713-733.
38. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
39. Jiang Q., Feng M.G., Mo Y.Y. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009, 9:194.
40. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
41. Wu S.Q., Voelkerding K.V., Sabatini L., Chen X.R., Huang J., Meisner L.F. Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562. Leukemia 1995, 9:858-862.
42. Calabretta B., Perrotti D. The biology of CML blast crisis. Blood 2004, 103:4010-4022.
43. + cells. Blood 2007, 109:4399-4405.
44. Machova Polakova K., Koblihova J., Stopka T. Role of epigenetics in chronic myeloid leukemia. Curr Hematol Malig Rep 2013, 8:28-36.
45. San Jose-Eneriz E., Roman-Gomez J., Jimenez-Velasco A., Garate L., Martin V., Cordeu L., et al. MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Mol Cancer 2009, 8:69.
46. Dentelli P., Rosso A., Orso F., Olgasi C., Taverna D., Brizzi M.F. MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 2010, 30:1562-1568.
47. Gabriely G., Yi M., Narayan R.S., Niers J.M., Wurdinger T., Imitola J., et al. Human glioma growth is controlled by microRNA-10b. Cancer Res 2011, 71:3563-3572.
48. Pogue A.I., Cui J.G., Li Y.Y., Zhao Y., Culicchia F., Lukiw W.J. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 2010, 476:18-22.
49. Chen R., Alvero A.B., Silasi D.A., Kelly M.G., Fest S., Visintin I., et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008, 27:4712-4723.
50. Song L., Huang Q., Chen K., Liu L., Lin C., Dai T., et al. MiR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun 2010, 402:135-140.
51. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
52. Dews M., Fox J.L., Hultine S., Sundaram P., Wang W., Liu Y.Y., et al. The myc-miR-17~92 axis blunts TGFβ signaling and production of multiple TGFβ-dependent antiangiogenic factors. Cancer Res 2010, 70:8233-8246.
53. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008, 68:8164-8172.
54. Lo S.S., Hung P.S., Chen J.H., Tu H.F., Fang W.L., Chen C.Y., et al. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma. Oncogene 2012, 31:226-237.
55. Shimizu S., Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010, 52:698-704.
56. Russ A.C., Sander S., Luck S.C., Lang K.M., Bauer M., Rucker F.G., et al. Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. Haematologica 2011, 96:1783-1791.
57. Suh S.S., Yoo J.Y., Nuovo G.J., Jeon Y.J., Kim S., Lee T.J., et al. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A 2012, 109:5316-5321.
58. Amir S., Ma A.H., Shi X.B., Xue L., Kung H.J., Devere White R.W. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One 2013, 8:e61064.
59. Zhong M., Bian Z., Wu Z. MiR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem 2013, 31:209-218.
60. Andersson L.C., Nilsson K., Gahmberg C.G. K562-a human erythroleukemic cell line. Int J Cancer 1979, 23:143-147.
61. Lozzio B.B., Lozzio C.B. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 1979, 3:363-370.
62. Sutherland J.A., Turner A.R., Mannoni P., McGann L.E., Turc J.M. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod 1986, 5:250-262.
63. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987, 70:1233-1244.
64. Goldberger A., Brewer G., Hnilica L.S., Briggs R.C. Nonhistone protein antigen profiles of five leukemic cell lines reflect the extent of myeloid differentiation. Blood 1984, 63:701-710.
65. Choong M.L., Yang H.H., McNiece I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 2007, 35:551-564.
66. Felli N., Fontana L., Pelosi E., Botta R., Bonci D., Facchiano F., et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 2005, 102:18081-18086.
67. Masaki S., Ohtsuka R., Abe Y., Muta K., Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 2007, 364:509-514.
68. Kong W., He L., Coppola M., Guo J., Esposito N.N., Coppola D., et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010, 285:17869-17879.
69. Rai D., Kim S.W., McKeller M.R., Dahia P.L., Aguiar R.C. Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis. Proc Natl Acad Sci U S A 2010, 107:3111-3116.
70. Wang Q., Huang Z., Xue H., Jin C., Ju X.L., Han J.D., et al. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008, 111:588-595.
71. Ribeil J.A., Zermati Y., Vandekerckhove J., Cathelin S., Kersual J., Dussiot M., et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 2007, 445:102-105.
72. Li N., Kaur S., Greshock J., Lassus H., Zhong X., Wang Y., et al. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res 2012, 72:154-164.
73. Tsang W.P., Kwok T.T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008, 13:1215-1222.
74. Suzuki Y., Kim H.W., Ashraf M., Haider H.Kh. Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol 2010, 299:H1077-H1082.
75. Hashimi S.T., Fulcher J.A., Chang M.H., Gov L., Wang S., Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009, 114:404-414.
76. Boucher J.M., Peterson S.M., Urs S., Zhang C., Liaw L. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem 2011, 286:28312-28321.
77. Calin G.A., Cimmino A., Fabbri M., Ferracin M., Wojcik S.E., Shimizu M., et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008, 105:5166-5171.
78. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
79. Yan Z., Shah P.K., Amin S.B., Samur M.K., Huang N., Wang X., et al. Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancers. Nucleic Acids Res 2012, 40:e135.
80. Yang J.H., Li J.H., Shao P., Zhou H., Chen Y.Q., Qu L.H. StarBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011, 39:D202-D209.
81. Zhang M.C., Lv Y., Qi Y.T., Zhang Z., Fu X.N., Yuan C.G., et al. Knockdown and overexpression of miR-219 lead to embryonic defects in zebrafish development. Fen Zi Xi Bao Sheng Wu Xue Bao 2008, 41:341-348.
82. Lize M., Pilarski S., Dobbelstein M. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 2010, 17:452-458.
83. Jongen-Lavrencic M., Sun S.M., Dijkstra M.K., Valk P.J., Lowenberg B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008, 111:5078-5085.
84. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12.
85. Pang R.T., Leung C.O., Ye T.M., Liu W., Chiu P.C., Lam K.K., et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010, 31:1037-1044.
86. Yekta S., Shih I.H., Bartel D.P. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004, 304:594-596.
87. Kinsella R.J., Kahari A., Haider S., Zamora J., Proctor G., Spudich G., et al. Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database 2011, 2011:bar030.
88. Wang L., Feng Z., Wang X., Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010, 26:136-138.
89. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
90. Carbon S., Ireland A., Mungall C.J., Shu S., Marshall B., Lewis S., et al. AmiGO: online access to ontology and annotation data. Bioinformatics 2009, 25:288-289.
91. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2:2366-2382.